Monday | October 15, 2018
SCOTT BILL PASSES SENATE; ONE STEP CLOSER TO THE WHITE HOUSE
WASHINGTON—The United States Senate has unanimously passed U.S. Senator Tim Scott’s Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act. Upon passage, Senator Scott released the following statement:
"One of the pillars I base my public service on is giving a voice to the voiceless, and that is exactly what my Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act does. I am thrilled that the Senate unanimously passed my bill to ensure that we work to improve our medical understanding of this disease through enhanced data collection and public health initiatives.
For far too long has this inherited disease been overshadowed in the public sphere and I am encouraged that, by the passage of it, our world-renowned medical communities will one day find a way to better treat and cure the 100,000 people across our nation who are affected. I encourage my House colleagues to examine the merits of the bill and work with me to ensure that it quickly heads to the President’s desk."
Background on Sickle Cell Disease:
Individuals diagnosed with Sickle Cell Disease may experience serious medical complications ranging from anemia, restricted blood flow, strokes and even death. While hematopoietic stem cell transplantation is currently the only known cure and advancements have been made in treating complications, more can be done to help patients and their families.
Read the full copy of the bill HERE